153.68 0.00 (0.00%)
After hours: 4:48PM EST
|Bid||153.65 x 1000|
|Ask||153.71 x 1000|
|Day's Range||153.20 - 155.00|
|52 Week Range||99.14 - 156.66|
|Beta (3Y Monthly)||0.89|
|PE Ratio (TTM)||39.10|
|Earnings Date||Feb 10, 2020 - Feb 14, 2020|
|Forward Dividend & Yield||1.48 (0.97%)|
|1y Target Est||167.33|
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
DexCom (DXCM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Steris (STE) delivered earnings and revenue surprises of 4.76% and 2.93%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
STERIS plc (STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 second quarter ended September 30, 2019. Revenue as reported for the quarter increased 9% to $736.8 million compared with $679.0 million in the second quarter of fiscal 2019, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 10% for the second quarter of fiscal 2020.
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DUBLIN, IRELAND, Oct. 22, 2019 -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 second.
How do we determine whether Steris Plc (NYSE:STE) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that […]
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see STERIS plc...
Dublin, Ireland, Aug. 26, 2019 -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Global Healthcare Conference on.
Today we'll look at STERIS plc (NYSE:STE) and reflect on its potential as an investment. In particular, we'll consider...
President & CEO of Steris Plc (30-Year Financial, Insider Trades) Walter M Rosebrough Jr (insider trades) sold 102,500 shares of STE on 08/08/2019 at an average price of $151.78 a share. Continue reading...
Steris (STE) delivered earnings and revenue surprises of 10.81% and 3.46%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
STERIS plc (STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 first quarter ended June 30, 2019. Revenue as reported for the quarter increased 9% to $696.8 million compared with $638.8 million in the first quarter of fiscal 2019, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 10% for the first quarter of fiscal 2020.